SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-001514
Filing Date
2021-01-20
Accepted
2021-01-20 08:25:44
Documents
8
Period of Report
2021-01-20

Document Format Files

Seq Description Document Type Size
1 6-K bntx-6k_20210120.htm 6-K 18074
2 EX-99.1 bntx-ex991_7.htm EX-99.1 49775
3 GRAPHIC gnaz4foyvehb000002.jpg GRAPHIC 9298
4 GRAPHIC g33pbj1zhbqa000004.jpg GRAPHIC 780
5 GRAPHIC g33pbj1zhbqa000001.jpg GRAPHIC 780
6 GRAPHIC gnaz4foyvehb000001.jpg GRAPHIC 14762
7 GRAPHIC g33pbj1zhbqa000002.jpg GRAPHIC 780
8 GRAPHIC g33pbj1zhbqa000003.jpg GRAPHIC 780
  Complete submission text file 0001564590-21-001514.txt   107188
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190847081
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39081 | Film No.: 21537447
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences